Analyst Price Target is $31.00
▼ -11.50% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for Apria in the last 3 months. The average price target is $31.00, with a high forecast of $38.00 and a low forecast of $26.00. The average price target represents a -11.50% upside from the last price of $35.03.
Current Consensus is
The current consensus among 5 polled investment analysts is to buy stock in Apria.
Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. The company was incorporated in 2018 and is headquartered in Indianapolis, Indiana.